This provider's $6.4M in total Medicare payments ranks in the 95th percentile of Ambulatory Surgical Center providers nationally.
Medicare payments to this provider grew 525% from 2014 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 58% in 2021
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $1.2K | $448.51 | 2.77x | $795.24 | $223.9K | 827 | 684 |
| 2015 | $1.3K | $485.44 | 2.66x | $804.34 | $265.9K | 908 | 783 |
| 2016 | $1.4K | $546.76 | 2.54x | $840.74 | $281.5K | 950 | 825 |
| 2017 | $1.6K | $535.12 | 2.98x | $1.1K | $375.6K | 1.2K | 1.1K |
| 2018 | $1.7K | $537.48 | 3.09x | $1.1K | $579.0K | 1.9K | 1.6K |
| 2019 | $2.6K | $1.2K | 2.23x | $1.4K | $709.2K | 2.0K | 1.7K |
| 2020 | $2.7K | $1.2K | 2.19x | $1.5K | $536.4K | 1.6K | 1.4K |
| 2021 | $1.7K | $684.59 | 2.47x | $1.0K | $845.5K | 2.5K | 2.2K |
| 2022 | $3.3K | $1.5K | 2.20x | $1.8K | $1.2M | 2.7K | 2.3K |
| 2023 | $4.0K | $1.7K | 2.40x | $2.3K | $1.4M | 2.8K | 2.4K |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | 13.3K | $2.9M | $219.99 | 3.81x |
| 55700 | Biopsy of prostate gland | 1.7K | $1.1M | $613.99 | 4.83x |
| 52310 | Removal of foreign body, stone, or stent from bladder canal (urethra) or bladder using an endoscope | 932 | $577.8K | $619.92 | 2.28x |
| C9740 | Cystourethroscopy, with insertion of transprostatic implant; 4 or more implants | 86 | $471.5K | $5.5K | 1.83x |
| 64561 | Insertion of sacral nerve neurostimulator electrode array | 95 | $361.3K | $3.8K | 2.37x |
| 52281 | Dilation of bladder canal (urethra) using an endoscope | 396 | $245.2K | $619.18 | 2.29x |
| 52224 | Destruction of (less than 0.5 centimeters) growths of the bladder and bladder canal (urethra) using an endoscope | 247 | $237.4K | $961.28 | 1.99x |
| 55874 | Injection of biodegradable material next to prostate | 57 | $154.0K | $2.7K | 3.29x |
| 52287 | Examination with injections of chemical for destruction of bladder using an endoscope | 196 | $125.2K | $638.60 | 2.10x |
| 52234 | Destruction and/or removal of (0.5 to 2.0 centimeters) small growths of the bladder using an endoscope | 85 | $92.6K | $1.1K | 1.55x |
| 52315 | Complicated removal of foreign body, stone, or stent from bladder canal (urethra) or bladder using an endoscope | 106 | $65.3K | $616.41 | 2.43x |
| 55876 | Placement of device in prostate for radiation therapy | 57 | $39.2K | $687.38 | 2.86x |
| 52204 | Biopsy of the bladder using an endoscope | 31 | $19.4K | $625.87 | 3.20x |
This provider submits charges 3.38 times higher than what Medicare actually pays.
A markup ratio of 3.38x means for every $100 Medicare pays, this provider initially charges $338. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Ambulatory Surgical Center providers in PA for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Main Line Surgery Center, Llc | Bala Cynwyd, PA | $38.7M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data